318 related articles for article (PubMed ID: 33247539)
21. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews.
Rock EM; Sullivan MT; Collins SA; Goodman H; Limebeer CL; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2020 Sep; 237(9):2621-2631. PubMed ID: 32488349
[TBL] [Abstract][Full Text] [Related]
22. Antiviral activities of hemp cannabinoids.
van Breemen RB; Simchuk D
Clin Sci (Lond); 2023 Apr; 137(8):633-643. PubMed ID: 37083031
[TBL] [Abstract][Full Text] [Related]
23. Cannabidiol in canine epilepsy.
Potschka H; Bhatti SFM; Tipold A; McGrath S
Vet J; 2022 Dec; 290():105913. PubMed ID: 36209995
[TBL] [Abstract][Full Text] [Related]
24. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract.
Śledziński P; Nowak-Terpiłowska A; Rzymski P; Słomski R; Zeyland J
Molecules; 2023 Dec; 28(23):. PubMed ID: 38067615
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements.
Wakshlag JJ; Cital S; Eaton SJ; Prussin R; Hudalla C
Vet Med (Auckl); 2020; 11():45-55. PubMed ID: 32346530
[TBL] [Abstract][Full Text] [Related]
27. Cannabidiol exerts protective effects in an in vitro model of Parkinson's disease activating AKT/mTOR pathway.
Gugliandolo A; Pollastro F; Bramanti P; Mazzon E
Fitoterapia; 2020 Jun; 143():104553. PubMed ID: 32184097
[TBL] [Abstract][Full Text] [Related]
28. Effect of combined doses of Δ
Rock EM; Sullivan MT; Pravato S; Pratt M; Limebeer CL; Parker LA
Psychopharmacology (Berl); 2020 Mar; 237(3):901-914. PubMed ID: 31897571
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid contents in hemp teas and estimation of their transfer into tea infusions.
Triesch N; Vijayakumar N; Weigel S; These A
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2023 Jul; 40(7):890-901. PubMed ID: 37417991
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Cannabidiol, Δ
ElSohly MA; Murphy TP; Khan I; Walker LW; Gul W
Med Cannabis Cannabinoids; 2020 Aug; 3(1):1-13. PubMed ID: 34676337
[TBL] [Abstract][Full Text] [Related]
31. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.
Rotolo MC; Graziano S; Pellegrini M; Corlazzoli D; Antinori L; Porcarelli L; Pichini S
Curr Pharm Biotechnol; 2017; 18(10):821-827. PubMed ID: 29173160
[TBL] [Abstract][Full Text] [Related]
32. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
Koturbash I; MacKay D
J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
[TBL] [Abstract][Full Text] [Related]
33. Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
Giacoppo S; Soundara Rajan T; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4906-19. PubMed ID: 26744883
[TBL] [Abstract][Full Text] [Related]
34. Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.
Corsato Alvarenga I; Panickar KS; Hess H; McGrath S
Annu Rev Anim Biosci; 2023 Feb; 11():227-246. PubMed ID: 36790884
[TBL] [Abstract][Full Text] [Related]
35. Valorization of CBD-hemp through distillation to provide essential oil and improved cannabinoids profile.
Zheljazkov VD; Maggi F
Sci Rep; 2021 Oct; 11(1):19890. PubMed ID: 34615971
[TBL] [Abstract][Full Text] [Related]
36. Cannabidiol alleviates hemorrhagic shock-induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway.
Lin B; Gao Y; Li Z; Zhang Z; Lin X; Gao J
Fundam Clin Pharmacol; 2020 Dec; 34(6):640-649. PubMed ID: 32215966
[TBL] [Abstract][Full Text] [Related]
37. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F
J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911
[TBL] [Abstract][Full Text] [Related]
38. Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.
Mogi C; Yoshida M; Kawano K; Fukuyama T; Arai T
Can Vet J; 2022 Apr; 63(4):423-426. PubMed ID: 35368394
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
40. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
